Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes

References

• ArnoldMKarim-KosHECoeberghJWRecent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer ObservatoryEur J Cancer20155191164118724120180
   PubMed Web of Science ®Google Scholar
• ThompsonIMTangenCMParadeloJAdjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow up of a randomized clinical trialJ Urol2009181395696219167731
   PubMed Web of Science ®Google Scholar
• BollaMvan PoppelHTombalBPostoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)Lancet201238098582018202723084481
   PubMed Web of Science ®Google Scholar
• WiegelTBartkowiakDBottkeDAdjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trialEur Urol201466224325024680359
   PubMed Web of Science ®Google Scholar
• ArcangeliSRamellaSde BariBFrancoPAlongiFD’AngelilloRMA cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspectiveCrit Rev Oncol Hematol20169732232726455883
   PubMed Web of Science ®Google Scholar
• SundaresanPTurnerSKneeboneAPearseMFraser-BrowneCWooHHDo screening trial recruitment logs accurately reflect the eligibility criteria of a given clinical trial? Early lessons from the RAVES 0803 trialClin Oncol2014266348352
   Web of Science ®Google Scholar
• GandagliaGBrigantiAClarkeNAdjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patientsEur Urol201772568970928189428
   PubMed Web of Science ®Google Scholar
• BrigantiAKarnesRJJoniauSPrediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomyEur Urol201466347948624345725
   PubMed Web of Science ®Google Scholar
• RADICALS [homepage on the Internet]Radiotherapy and androgen deprivation in combination after local surgery Available from: http://www.radicals-trial.org/Accessed September 27, 2018
   Google Scholar
• ANZCTR [homepage on the Internet]Radiotherapy following radical prostatectomy - Adjuvant Versus Early Salvage Available from: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83910Accessed September 27, 2018
   Google Scholar
• BellavitaRMassettiMAbrahaIConformal postoperative radiotherapy in patients with positive resection margins and/or pT3-4 prostate adenocarcinomaInt J Radiat Oncol Biol Phys2012843e299e30422572075
   PubMed Web of Science ®Google Scholar
• OstPFonteyneVVilleirsGLumenNOosterlinckWDe MeerleerGAdjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patientsEur Urol200956466967519501453
   PubMed Web of Science ®Google Scholar
• CozzariniCMontorsiFFiorinoCNeed for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patientsInt J Radiat Oncol Biol Phys200975496697419619960
   PubMed Web of Science ®Google Scholar
• ZilliTJorcanoSPeguretNDose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysisActa Oncol20145319610224032443
   PubMed Web of Science ®Google Scholar
• GhadjarPHayozSBernhardJAcute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10J Clin Oncol201533354158416626527774
   PubMed Web of Science ®Google Scholar
• BenjaminLCTreeACDearnaleyDPThe Role of Hypofractionated Radiotherapy in Prostate CancerCurr Oncol Rep20171943028343352
   PubMed Web of Science ®Google Scholar
• MichalskiJMLawtonCEl NaqaIDevelopment of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerInt J Radiat Oncol Biol Phys201076236136819394158
   PubMed Web of Science ®Google Scholar
• LawtonCAMichalskiJEl-NaqaIRTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancerInt J Radiat Oncol Biol Phys200974238338718947938
   PubMed Web of Science ®Google Scholar
• ThompsonIMValicentiRKAlbertsenPAdjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO GuidelineJ Urol2013190244144923707439
   PubMed Web of Science ®Google Scholar
• SiepeGBuwengeMNguyenNPPostoperative Hypofractionated radiation therapy in prostate carcinoma: a systematic reviewAnticancer Res20183831221123029491044
   PubMed Web of Science ®Google Scholar
• DasuAToma-DasuIProstate alpha/beta revisited – an analysis of clinical results from 14 168 patientsActa Oncol201251896397422966812
   PubMed Web of Science ®Google Scholar
• BrennerDJMartinezAAEdmundsonGKMitchellCThamesHDArmourEPDirect evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissueInt J Radiat Oncol Biol Phys200252161311777617
   PubMed Web of Science ®Google Scholar
• IncrocciLWortelRCAlemayehuWGHypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialLancet Oncol20161781061106927339116
   PubMed Web of Science ®Google Scholar
• LeeWRDignamJJAminMBRandomized Phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancerJ Clin Oncol201634202325233227044935
   PubMed Web of Science ®Google Scholar
• ArcangeliGSaracinoBArcangeliSModerate Hypofractionation in high-risk, organ-confined prostate cancer: final results of a Phase III randomized trialJ Clin Oncol201735171891189728355113
   PubMed Web of Science ®Google Scholar
• AlongiFCozziLFogliataAHypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancerAnticancer Res201333104537454324123027
   PubMed Web of Science ®Google Scholar
• MassaccesiMCillaSDeodatoFHypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trialAnticancer Res20133362785278923749942
   PubMed Web of Science ®Google Scholar
• LewisSLPatelPSongHImage guided Hypofractionated Postprostatectomy intensity modulated radiation therapy for prostate cancerInt J Radiat Oncol Biol Phys201694360561126867889
   PubMed Web of Science ®Google Scholar
• MacchiaGSiepeGCapocacciaIHypofractionated postoperative IMRT in prostate carcinoma: a Phase I/II StudyAnticancer Res201737105821582828982907
   PubMed Web of Science ®Google Scholar
• FersinoSTebanoUMazzolaRModerate Hypofractionated Post-prostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute ToxicityClin Genitourin Cancer2017154e667e67328237181
   PubMed Web of Science ®Google Scholar
• CozzariniCFiorinoCDeantoniCHigher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patientsEur Urol20146661024103024985964
   PubMed Web of Science ®Google Scholar
• WongGWPalazzi-ChurasKLJarrardDFSalvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomyInt J Radiat Oncol Biol Phys200870244945517869014
   PubMed Web of Science ®Google Scholar
• KatayamaSStrieckerTKesselKHypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trialInt J Radiat Oncol Biol Phys201490492693325216858
   PubMed Web of Science ®Google Scholar
• KruserTJJarrardDFGrafAKEarly hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrenceCancer2011117122629263621656740
   PubMed Web of Science ®Google Scholar
• BarraSBelgioiaLMarcenaroMModerate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcomeCancer Manag Res201810473480 eCollection 201829559810
   PubMed Web of Science ®Google Scholar
• PicardiCPerretIMiralbellRZilliTHypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?Cancer Treat Rev201862919629178983
   PubMed Web of Science ®Google Scholar
• LatorzeffISargosPLoosGSupiotSGuerifSCarrieCDelineation of the prostate bed: The “Invisible Target” is still an issue?Front Oncol20177108 eCollection 201728620579
   PubMed Web of Science ®Google Scholar
• SilvermanJMKrebsTLMR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomyAJR Am J Roentgenol199716823793859016212
   PubMed Web of Science ®Google Scholar
• KoECMichaudALValicentiRKPostoperative radiation after radical prostatectomySemin Radiat Oncol2017271506627986212
   PubMed Web of Science ®Google Scholar
• SpiottoMTHancockSLKingCRRadiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patientsInt J Radiat Oncol Biol Phys2007691546117459606
   PubMed Web of Science ®Google Scholar
• PommierPChabaudSLagrangeJLIs There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized StudyInt J Radiat Oncol Biol Phys201696475976927788949
   PubMed Web of Science ®Google Scholar
• LongobardiBBerardiGFiorinoCAnatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with TomotherapyRadiother Oncol2011101346046421864924
   PubMed Web of Science ®Google Scholar
• FiorinoCCozzariniCRancatiTModelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapyInt J Radiat Oncol Biol Phys20149051250125725442349
   PubMed Web of Science ®Google Scholar
• PoortmansPBossiAVandeputteKGuidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology GroupRadiother Oncol200784212112717706307
   PubMed Web of Science ®Google Scholar
• NathSKSandhuAPRoseBSToxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancerInt J Radiat Oncol Biol Phys201078243544119939580
   PubMed Web of Science ®Google Scholar
• AzelieCGauthierMMirjoletCExclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groupsRadiat Oncol2012715822978763
   PubMed Web of Science ®Google Scholar